Evidence map›Paper›PMID 27376754›Full record

ReviewClinical rheumatology2017

Voriconazole-induced periostitis: a new rheumatic disorder.

Marwan H Adwan

Abstract readReview
PubMed Publisher
In one paragraph

Review in Clinical rheumatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. Skeletal Fluorosis: A Case Report of Rare Diagnosis of Computer-cleaner Toxicosis.Clinical practice and cases in emergency medicine · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Painful swelling of the index finger.Skeletal radiology · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Marwan H AdwanDepartment of Medicine, Division of Rheumatology, The University of Jordan, Queen Rania Street, Amman, 11942, Jordan. marwan.adwan@ju.edu.jo.
University of Jordan · JO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the past few years, several reports of periostitis affecting patients treated with voriconazole appeared in the literature. As rheumatologists are likely to be called to see such patients, a review of the reported cases was undertaken. A systematic search of Pubmed and Google scholar for case reports, case series and observational studies was undertaken. Twenty-six articles including 23 case reports/case series (total 40 patients), a prospective study and two retrospective studies of 58 cases were included. Age ranged from 3 months to 77 years. Eleven cases (27.5 %) were male and 29 cases (72.5 %) were female. The duration of treatment varied from 6 weeks to 8 years (mean 53.6, SD 77.4 weeks). Most cases presented with diffuse skeletal pain affecting various sites in association with elevated alkaline phosphatase. Periostitis is increasingly reported and should be considered in patients taking voriconazole who present with bone pain and/or alkaline phosphatase elevation.

Indexed as

AdolescentAdultAgedAlkaline PhosphataseAntifungal AgentsChildChild, PreschoolFemaleHumansInfantMaleMiddle AgedPeriostitisVoriconazoleYoung AdultAlkaline PhosphataseAntifungal AgentsVoriconazoleDrug-induced rheumatic conditionsFluorosisPeriostitisVoriconazole

Identifiers

PMID27376754
OpenAlexW2467639859

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.